license

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX:…

3 weeks ago

DerivaDEX LAUNCHES ITS LICENSED DERIVATIVES TRADING PLATFORM, MARKING THE FIRST DAO-GOVERNED DEFI EXCHANGE TO OPERATE WITH A REGULATORY LICENSE

HAMILTON, Bermuda, Feb. 17, 2026 /PRNewswire/ -- DerivaDEX today announced the launch of its platform and the start of derivatives trading…

3 weeks ago

FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and…

1 month ago

Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform

LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled…

2 months ago

Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement

Saint-Herblain (France), Pune, (India), December 31, 2025 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum…

2 months ago

Weebit Nano secures a license agreement with Texas Instruments

HOD HASHARON, Israel, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Weebit Nano Limited (ASX:WBT) (Weebit or Company), a leading developer and…

2 months ago

KuCoin EU Secures MiCAR License to Deliver Regulated Digital Asset Services In Europe

VIENNA, Austria, Nov. 28, 2025 /PRNewswire/ -- KuCoin, a leading global crypto platform built on trust, today announced that its European…

3 months ago

Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy

Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…

4 months ago

Bahrain’s Golden License Strikes Gold: USD 4.4 Billion Inflows Revealed at Gateway Gulf Showcasing the Island Nation’s Global Investment Appeal

The latest batch of Golden Licenses span across diversified sectors namely tech, real estate, and green manufacturing, contributing to economic…

4 months ago

Alvotech Provides Update on the Status ofU.S. Biologics License Application for AVT05

REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…

4 months ago